Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Protagonist Therapeutics (PTGX) Tax Provisions: 2018-2024

Historic Tax Provisions for Protagonist Therapeutics (PTGX) over the last 4 years, with Dec 2024 value amounting to $4.2 million.

  • Protagonist Therapeutics' Tax Provisions rose 128.57% to $200,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $1.1 million, marking a year-over-year decrease of 72.95%. This contributed to the annual value of $4.2 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Protagonist Therapeutics' Tax Provisions is $4.2 million, which was up 223.37% from $1.3 million recorded in FY2020.
  • Protagonist Therapeutics' 5-year Tax Provisions high stood at $4.2 million for FY2024, and its period low was $1.3 million during FY2020.
  • In the last 1 years, Protagonist Therapeutics' Tax Provisions had a median value of $4.2 million in 2024 and averaged $4.2 million.
  • Data for Protagonist Therapeutics' Tax Provisions shows a peak YoY skyrocketed of 286.43% (in 2020) over the last 5 years.
  • Protagonist Therapeutics' Tax Provisions (Yearly) stood at $1.3 million in 2020, then followed by $4.2 million in 2024.